Farmabol

Farmabol is a Polish pharmaceutical and medical device company founded in 2004 and officially registered in 2009. Headquartered in Limanowa, Poland, with an office in Kraków and a US office in Atlanta, Georgia, the company specializes in the distribution and manufacture of innovative self-diagnostic tests, medical devices, and wellness products. Its commercial portfolio includes the Neosana brand, which features blood-based pregnancy tests, female condoms, and CBD-infused tampons. Beyond commercial distribution, Farmabol actively engages in research and development, collaborating with academic institutions and investing in biotech spin-offs. Notably, Farmabol was the initial investor in SCImmune, a spin-off from the Medical University of Lodz developing the 'MS-test,' an in vitro diagnostic test for the early detection of multiple sclerosis based on autoreactive T-cell expansion.